- Home
- CBRE vs RGC Comparison
CBRE vs RGC Comparison
Compare CBRE & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRE
- RGC
- Stock Information
- Founded
- CBRE 1906
- RGC 2014
- Country
- CBRE United States
- RGC Hong Kong
- Employees
- CBRE N/A
- RGC N/A
- Industry
- CBRE Real Estate
- RGC Medicinal Chemicals and Botanical Products
- Sector
- CBRE Finance
- RGC Health Care
- Exchange
- CBRE Nasdaq
- RGC Nasdaq
- Market Cap
- CBRE 44.0B
- RGC 38.6B
- IPO Year
- CBRE 2004
- RGC 2021
- Fundamental
- Price
- CBRE $159.10
- RGC $12.56
- Analyst Decision
- CBRE Buy
- RGC
- Analyst Count
- CBRE 9
- RGC 0
- Target Price
- CBRE $158.00
- RGC N/A
- AVG Volume (30 Days)
- CBRE 1.7M
- RGC 275.6K
- Earning Date
- CBRE 07-29-2025
- RGC 06-30-2025
- Dividend Yield
- CBRE N/A
- RGC N/A
- EPS Growth
- CBRE 19.77
- RGC N/A
- EPS
- CBRE 3.57
- RGC N/A
- Revenue
- CBRE $38,104,000,000.00
- RGC N/A
- Revenue This Year
- CBRE $14.17
- RGC N/A
- Revenue Next Year
- CBRE $9.03
- RGC N/A
- P/E Ratio
- CBRE $44.60
- RGC N/A
- Revenue Growth
- CBRE 14.96
- RGC N/A
- 52 Week Low
- CBRE $108.45
- RGC $0.09
- 52 Week High
- CBRE $161.81
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- CBRE 63.91
- RGC 43.67
- Support Level
- CBRE $156.91
- RGC $12.12
- Resistance Level
- CBRE $161.81
- RGC $13.33
- Average True Range (ATR)
- CBRE 2.37
- RGC 0.72
- MACD
- CBRE -0.21
- RGC 0.14
- Stochastic Oscillator
- CBRE 68.34
- RGC 20.56
About CBRE CBRE Group Inc
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.